At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Proparacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
In Brief
A clinical study evaluating Proparacaine and Conjunctival culture for Age-related Macular Degeneration and 4 related conditions. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAge-related Macular Degeneration, Diabetic Macular Edema, Injection Site, Injection Site Infection, Pain, Postoperative
CountriesUnited States
CollaboratorsVitreoRetinal Surgery, PA, Research to Prevent Blindness
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedNov 2016
Primary CompletionFeb 2018
TodayJul 2026
First PostedNov 1, 2016
Enrollment StartOct 12, 2016
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.7 years ago
Interventions
Proparacainedrug
Extra proparacaine will be applied to the conjunctival surface to determine its role in patient experience.
Conjunctival cultureprocedure
Conjunctival cultures will be performed to ensure that the intervention does not interfere with antisepsis.